• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猪动静脉移植物狭窄模型中异常的可溶性环氧化物水解酶和氧化脂质水平。

Aberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis model.

作者信息

Terry Christi M, Carlson Mary L, He Yuxia, Ulu Arzu, Morisseau Christophe, Blumenthal Donald K, Hammock Bruce D, Cheung Alfred K

机构信息

Division of Nephrology and Hypertension, University of Utah, Utah, USA.

出版信息

J Vasc Res. 2014;51(4):269-82. doi: 10.1159/000365251. Epub 2014 Sep 5.

DOI:10.1159/000365251
PMID:25196102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4235611/
Abstract

Synthetic arteriovenous grafts (AVGs) used for hemodialysis frequently fail due to the development of neointimal hyperplasia (NH) at the vein-graft anastomosis. Inflammation and smooth-muscle cell (SMC) and myofibroblast proliferation and migration likely play an important role in the pathogenesis of NH. Epoxyeicosatrienoic acids (EETs), the products of the catabolism of arachidonic acid by cytochrome P450 enzymes, possess anti-inflammatory, antiproliferative, antimigratory and vasodilatory properties that should reduce NH. The degradation of vasculoprotective EETs is catalyzed by the enzyme, soluble epoxide hydrolase (sEH). sEH upregulation may thus contribute to NH development by the enhanced removal of vasculoprotective EETs. In this study, sEH, cytochrome P450 and EETs were examined after AVG placement in a porcine model to explore their potential roles in AVG stenosis. Increased sEH protein expression, decreased P450 epoxygenase activity and dysregulation of 5 oxylipin mediators were observed in the graft-venous anastomotic tissues when compared to control veins. Pharmacological inhibitors of sEH decreased the growth factor-induced migration of SMCs and fibroblasts, although they had no significant effect on the proliferation of these cells. These results provide insights on epoxide biology in vascular disorders and a rationale for the development of novel pharmacotherapeutic strategies to prevent AVG failure due to NH and stenosis.

摘要

用于血液透析的合成动静脉移植物(AVG)常常因静脉-移植物吻合处新内膜增生(NH)的发展而失效。炎症、平滑肌细胞(SMC)以及肌成纤维细胞的增殖和迁移可能在NH的发病机制中起重要作用。环氧二十碳三烯酸(EETs)是细胞色素P450酶催化花生四烯酸分解的产物,具有抗炎、抗增殖、抗迁移和血管舒张特性,应能减少NH。血管保护型EETs的降解由可溶性环氧化物水解酶(sEH)催化。因此,sEH上调可能通过增强对血管保护型EETs的清除而促进NH的发展。在本研究中,在猪模型中植入AVG后检测了sEH、细胞色素P450和EETs,以探讨它们在AVG狭窄中的潜在作用。与对照静脉相比,在移植物-静脉吻合组织中观察到sEH蛋白表达增加、P450环氧化酶活性降低以及5-氧脂素介质失调。sEH的药理抑制剂减少了生长因子诱导的SMC和成纤维细胞迁移,尽管它们对这些细胞的增殖没有显著影响。这些结果为血管疾病中的环氧化物生物学提供了见解,并为开发新的药物治疗策略以预防因NH和狭窄导致的AVG失效提供了理论依据。

相似文献

1
Aberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis model.猪动静脉移植物狭窄模型中异常的可溶性环氧化物水解酶和氧化脂质水平。
J Vasc Res. 2014;51(4):269-82. doi: 10.1159/000365251. Epub 2014 Sep 5.
2
Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.可溶性环氧化物水解酶在猪动静脉移植物狭窄模型中的表达及可溶性环氧化物水解酶抑制剂的抗炎作用。
Am J Physiol Cell Physiol. 2012 Aug 1;303(3):C278-90. doi: 10.1152/ajpcell.00386.2011. Epub 2012 May 23.
3
Prevention of Venous Neointimal Hyperplasia by a Multitarget Receptor Tyrosine Kinase Inhibitor.多靶点受体酪氨酸激酶抑制剂预防静脉内膜增生
J Vasc Res. 2015;52(4):244-256. doi: 10.1159/000442977. Epub 2016 Jan 21.
4
Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.可溶性环氧化物水解酶通过调节平滑肌细胞迁移参与动脉粥样硬化的发展和动脉内膜形成。
Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1894-903. doi: 10.1152/ajpheart.00289.2015. Epub 2015 Oct 9.
5
Intimal smooth muscle cells are a source but not a sensor of anti-inflammatory CYP450 derived oxylipins.内膜平滑肌细胞是抗炎性细胞色素P450衍生的氧化脂质的来源,但不是传感器。
Biochem Biophys Res Commun. 2015 Aug 7;463(4):774-80. doi: 10.1016/j.bbrc.2015.06.012. Epub 2015 Jun 15.
6
Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells.可溶性环氧化物水解酶抑制剂对血管平滑肌细胞增殖和迁移的影响差异。
Int J Mol Sci. 2017 Dec 11;18(12):2683. doi: 10.3390/ijms18122683.
7
Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.细胞色素P450环氧合酶衍生的类花生酸对血管平滑肌细胞迁移的抑制作用。
Circ Res. 2002 May 17;90(9):1020-7. doi: 10.1161/01.res.0000017727.35930.33.
8
Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response.细胞色素 P450-环氧合酶和可溶性环氧合酶在血管反应调节中的作用。
Adv Pharmacol. 2023;97:37-131. doi: 10.1016/bs.apha.2022.12.003. Epub 2023 Jan 2.
9
Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases.人可溶性环氧化物水解酶在血管内皮细胞中的过表达(Tie2-sEH Tr)减轻小鼠冠状动脉反应性充血:氧化脂质和ω-羟化酶的作用
PLoS One. 2017 Jan 5;12(1):e0169584. doi: 10.1371/journal.pone.0169584. eCollection 2017.
10
Nox4 and soluble epoxide hydrolase synergistically mediate homocysteine-induced inflammation in vascular smooth muscle cells.Nox4 和可溶性环氧化物水解酶协同介导同型半胱氨酸诱导的血管平滑肌细胞炎症。
Vascul Pharmacol. 2019 Sep;120:106544. doi: 10.1016/j.vph.2019.01.001. Epub 2019 Jan 2.

本文引用的文献

1
The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension.可溶性环氧化物水解酶抑制剂AR9281可降低血压、改善高血压患者的肾损伤并改善血管功能。
Pharmaceuticals (Basel). 2009 Dec 18;2(3):217-227. doi: 10.3390/ph2030217.
2
EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells.EETs 和 CYP2J2 抑制 TNF-α 诱导的肺动脉内皮细胞凋亡和 TGF-β1 诱导的肺动脉平滑肌细胞迁移。
Int J Mol Med. 2013 Sep;32(3):685-93. doi: 10.3892/ijmm.2013.1435. Epub 2013 Jul 5.
3
Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients.
细胞色素 P450 衍生的类二十烷酸和冠心病患者的血管功能障碍。
Atherosclerosis. 2013 Apr;227(2):442-8. doi: 10.1016/j.atherosclerosis.2013.01.034. Epub 2013 Feb 5.
4
Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.可溶性环氧化物水解酶在猪动静脉移植物狭窄模型中的表达及可溶性环氧化物水解酶抑制剂的抗炎作用。
Am J Physiol Cell Physiol. 2012 Aug 1;303(3):C278-90. doi: 10.1152/ajpcell.00386.2011. Epub 2012 May 23.
5
A biodegradable perivascular wrap for controlled, local and directed drug delivery.一种可生物降解的血管周围包裹物,用于控制、局部和定向药物输送。
J Control Release. 2012 Jul 10;161(1):81-9. doi: 10.1016/j.jconrel.2012.04.029. Epub 2012 Apr 27.
6
Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization.在氧诱导的缺血性视网膜病变和增生性糖尿病性视网膜病变中,12-脂氧合酶的表达和活性增加:在视网膜新生血管形成中的意义。
Diabetes. 2011 Feb;60(2):614-24. doi: 10.2337/db10-0008. Epub 2011 Jan 12.
7
Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.可溶性环氧化物水解酶抑制可减轻糖尿病、肥胖症和高血压动物模型中的内皮功能障碍。
Eur J Pharmacol. 2011 Mar 1;654(1):68-74. doi: 10.1016/j.ejphar.2010.12.016. Epub 2010 Dec 25.
8
PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms.血小板衍生生长因子诱导人动脉和静脉平滑肌细胞增殖:PDGF 同工型产生不同作用的分子基础。
J Cell Biochem. 2011 Jan;112(1):289-98. doi: 10.1002/jcb.22924.
9
Chronic treatment with epoxyeicosatrienoic acids modulates insulin signaling and prevents insulin resistance in hepatocytes.慢性给予环氧二十碳三烯酸可调节肝细胞中的胰岛素信号转导并预防胰岛素抵抗。
Prostaglandins Other Lipid Mediat. 2011 Feb;94(1-2):3-8. doi: 10.1016/j.prostaglandins.2010.10.002. Epub 2010 Oct 30.
10
Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.可溶性环氧化物水解酶缺乏可减轻高脂血症小鼠股动脉套管模型中的新生内膜形成。
Arterioscler Thromb Vasc Biol. 2010 May;30(5):909-14. doi: 10.1161/ATVBAHA.110.204099. Epub 2010 Mar 11.